Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric, Randomized, Double-blind, Controlled Clinical Trial to Assess the Efficacy and Safety of Bemiparin Sodium as Treatment of Diabetic Foot Ulcers

NCT00448903 is registered in ClinicalTrials.gov with Rovi Pharmaceuticals Laboratories as lead sponsor.

NCT NCT00448903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00448903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric, Randomized, Double-blind, Controlled Clinical Trial to Assess the Efficacy and Safety of Bemiparin Sodium as Treatment of Diabetic Foot Ulcers
Lead sponsor
Rovi Pharmaceuticals Laboratories
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2007
Completion date
April 30, 2010
Enrollment
329 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

foot ulcer, diabetic